US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 4.540
  • -0.220-4.62%
Close Mar 18 16:00 ET
  • 4.540
  • 0.0000.00%
Post 16:00 ET
205.29MMarket Cap-6.78P/E (TTM)

Y-mAbs Therapeutics Key Stats

Y-mAbs Therapeutics Q4 2024 Earnings Date

Currency:USDMar 4, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
26.70M
26.50M
-206.38K
Miss Est.
+14.29%
+13.41%
-0.77%
EPS
-0.12
-0.15
-0.03
Miss Est.
-485.93%
-650.00%
-28.64%
Strong Buy

Mar 18, 2025

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.758M--
--2025/Q1-- / 19.770M--
Mar 4, 20252024/Q426.495M / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.758M--
--2025/Q1-- / 19.770M--
Mar 4, 20252024/Q426.495M / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 18, 2025

Strong Buy

  • Buy

    88.89%
  • Hold

    11.11%
  • Sell

    0.00%

Price Target

No Data